Skip to main content
. 2014;16(3):122–130.

Figure 3.

Figure 3

Potential modalities to be used as a combinatorial approach for castration-resistant prostate cancer. Reproduced with permission from Galsky MD et al.24 CYP17 indicates a cytochrome p450 complex involved in adrenal steroidal synthesis; Met RTK, Met receptor tyrosine kinase; VEGFR2, vascular endothelial growth factor receptor 2; RANKL, receptor activator of nuclear factor k-B ligand; RANK, receptor activator of nuclear factor k-B.